{"id":"https://openalex.org/W3013977299","doi":"https://doi.org/10.1158/2326-6074.tumimm19-ia08","title":"Abstract IA08: Understanding resistance to develop next-generation CART for lymphoid malignancies","display_name":"Abstract IA08: Understanding resistance to develop next-generation CART for lymphoid malignancies","publication_year":2020,"publication_date":"2020-03-01","ids":{"openalex":"https://openalex.org/W3013977299","doi":"https://doi.org/10.1158/2326-6074.tumimm19-ia08","mag":"3013977299"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm19-ia08","doi":"https://doi.org/10.1158/2326-6074.tumimm19-ia08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm19-ia08","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088355904","display_name":"Marco Ruella","orcid":"https://orcid.org/0000-0003-4301-5811","observed_orcids":["https://orcid.org/0000-0003-4301-5811"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marco Ruella","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088355904"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"3_Supplement","first_page":"IA08","last_page":"IA08"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9480000138282776},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.5759999752044678},{"id":"https://openalex.org/keywords/anti-cd19-antibody","display_name":"anti-CD19","score":0.7080000042915344},{"id":"https://openalex.org/keywords/lymphoid-malignancies","display_name":"lymphoid malignancies","score":0.8709999918937683},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.7699999809265137},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7570000290870667},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.6639999747276306},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C2777275308","wikidata":"https://www.wikidata.org/wiki/Q234668","display_name":"Cart","level":2,"score":0.9118902087211609},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7493165731430054},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6868288516998291},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6624679565429688},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6615431308746338},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6142726540565491},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5326074361801147},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4829222857952118},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.43691694736480713},{"id":"https://openalex.org/C3019255331","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive immunotherapy","level":4,"score":0.430719256401062},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4273689389228821},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.38017427921295166},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35656261444091797},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.27865591645240784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.164271742105484},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm19-ia08","doi":"https://doi.org/10.1158/2326-6074.tumimm19-ia08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm19-ia08","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3110234128","https://openalex.org/W4361285157","https://openalex.org/W3135234497","https://openalex.org/W4398162637","https://openalex.org/W3136689359","https://openalex.org/W4281752045","https://openalex.org/W2756143810","https://openalex.org/W2769608655","https://openalex.org/W2972821576","https://openalex.org/W3048560783"],"abstract_inverted_index":{"Abstract":[0],"Adoptive":[1],"T-cell":[2],"therapies,":[3],"and":[4,25,60,70,96],"in":[5,18,22,53],"particular":[6],"chimeric":[7],"antigen":[8],"receptor":[9],"T":[10],"cells":[11],"(CART),":[12],"are":[13],"leading":[14],"to":[15,78],"significant":[16,29],"responses":[17],"cancer":[19],"patients,":[20],"particularly":[21],"B-cell":[23],"leukemias":[24],"lymphomas.":[26],"However,":[27],"a":[28],"subset":[30],"of":[31,56,88],"patients":[32],"still":[33],"do":[34],"not":[35],"respond":[36],"or":[37],"eventually":[38],"relapse":[39,57],"after":[40,58],"anti-CD19":[41],"CART":[42,68,81],"therapy.":[43],"In":[44],"his":[45],"talk,":[46],"Dr.":[47],"Ruella":[48],"will":[49],"highlight":[50],"recent":[51],"finding":[52],"the":[54,89],"pathogenesis":[55],"CART19":[59],"discuss":[61],"novel":[62],"therapeutic":[63],"approaches":[64],"aimed":[65],"at":[66],"increasing":[67],"feasibility":[69],"efficacy.":[71],"Citation":[72],"Format:":[73],"Marco":[74],"Ruella.":[75],"Understanding":[76],"resistance":[77],"develop":[79],"next-generation":[80],"for":[82],"lymphoid":[83],"malignancies":[84],"[abstract].":[85],"In:":[86],"Proceedings":[87],"AACR":[90],"Special":[91],"Conference":[92],"on":[93],"Tumor":[94],"Immunology":[95],"Immunotherapy;":[97],"2019":[98],"Nov":[99],"17-20;":[100],"Boston,":[101],"MA.":[102],"Philadelphia":[103],"(PA):":[104],"AACR;":[105],"Cancer":[106],"Immunol":[107],"Res":[108],"2020;8(3":[109],"Suppl):Abstract":[110],"nr":[111],"IA08.":[112]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2020-04-03T00:00:00"}